INVESTORS' PRESENTATION Our Pharmacy Operations Check out our pharmacy industry overview study ‍ We provide prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long term care facilities, contracted pharmacy services for 340B Covered Entities under the 340B Drug Discount Pricing Program, and health practice risk management. We improve the lives of patients with complex chronic diseases through our partnerships with patients, payors, pharmaceutical manufacturers and distributors, and physicians. We offer a broad range of innovative solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. We also provide patient health risk reviews and free same-day delivery. We currently fill on average approximately 44,000prescriptions per month. We believe we are well positioned to continue expanding our market share in the pharmacy industry. We offer a variety of value-added services for no additional charge that further encourage satisfaction across all medication stake holders and enhance loyalty and key performance metrics. These services include language support for broad demographics, prior authorization assistance, same-day home-medication delivery, on site provider consultation services, reporting and analytics, customized medication adherence packaging solutions, and patient advocacy. Our pharmacies accept most major insurance plans and provide access to co-pay assistance programs, discount and manufacturer coupons, and competitive cash payment options. We also offer e-commerce of over-the-counter products, certain disease testing, and vaccinations. We enhance patient adherence to complex drug regimens, collect and report data, and ensure effective dispensing of medications to support the needs of patients, providers, and payors. Our patient and provider support services ensure appropriate drug initiation, facilitate patient compliance and persistence, and capture important information regarding safety and effectiveness of the medications that we dispense. We have filled over 258,000prescription during the six months ended June 30, 2020, compared to 187,000prescriptions for the same period in 2019. Increases in prescriptions filled, physician referrals, and patients serviced stem from our value-added services and our performance as measured by Health Insurance Plans and PBMs. In 2019, our performance score was Five Stars with a relative ranking in the top 20% of all pharmacies in the U.S. Primary care physicians similarly are measured based on chronic care management, the results of which impact their annual revenue. This creates incentive for physicians to refer patients to pharmacies that have high performance scores. As a result of our pharmacy performance and value-added services we have helped retain customers and attract new ones and have resulted in performance incentives from PBMs of approximately$724,000 in 2019. We provide contracted pharmacy services for 340B Covered Entities under the 340B Drug Discount Pricing Program. The drugs are owned by the 340B Covered Entity up until sale, so we do not incur out of pocket costs for this drug inventory. Under the terms of these agreements, we act as a pass through for reimbursements on prescription claims adjudicated on behalf of the 340B Covered Entities and receive a dispensing fee per prescription. These fees vary by the covered entity and the level of service we provide. In 2015, we established a non-sterile compounding lab to support those patients looking for alternative primarily topical pain management treatments and customizable dosage forms to accommodate struggles with existing conditions. Our compounding department specializes in formularies such as non-narcotic topical pain creams, wound care creams, scar gels, hormone replacement therapies, female health, pediatrics, and sports medicine. We only use FDA approved and registered ingredients and each compounded prescription can be individually tailored for a result that fully meet the needs of the patient. In addition to these medications, PharmCo prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules which are 100% Kosher and Halal certified. Compounded medications require strict compliance procedures, are highly labor intensive and as of 2020 are largely not covered by insurance. However, we continue to believe that compounded options must be available for our patients as they have proven effective in improving quality of life for patients with complex conditions and treatment regimens. For our LTC customers, we providepurchasing, custom packaging and dispensing of both prescription andnon-prescription pharmaceutical products. We utilize a best practice unit-of-dose packaging system as opposed to thetraditional vials, using the same robotic packaging systems currently used bychain, mail order, and large-scale pharmacies. We also provide computerized maintenance of patient prescription histories,third party billing and consultant pharmacist services. Our consultant pharmacyservices consist primarily of evaluation of monthly patient drug therapy, aswell as monitoring the institution’s drug distribution system. We also generate revenue from ourwork in MTM. MTM involves review and adjustment of prescribed drug therapies toimprove patient health outcomes for patients with multiple prescriptions. Thisprocess includes several activities such as performing patient assessments,creating medication treatment plans, monitoring the effectiveness of andadherence to prescribed therapies and delivering documentation of theseservices to the patient’s physician to coordinate comprehensive care. We currently deliver prescriptions toFlorida’s diverse population and ship compounded medications to patients instates where we hold non-resident pharmacy licenses as well. We hold acommunity pharmacy permit in Florida and we hold non-resident pharmacy licensesthat allow us to dispense to patients in the following states: Arizona, Colorado,Connecticut, Georgia, Illinois, Massachusetts, Minnesota, Nevada, New Jersey, New York, Pennsylvania, Texas,and Utah. Investors' Presentation Full overview of RXMD's performance DOWNLOAD NOW CONTACT US: INFO@PROGRESSIVECAREUS.COM COMPANY OVERVIEW NEWS STOCK INVESTOR'S FAQ CONTACT US PRIVACY POLICY ACCREDITED AS SEEN ON COPYRIGHT 2020 © PROGRESSIVE CARE INC. FORWARD-LOOKING STATEMENTS – CERTAINSTATEMENTS INCLUDED IN THIS PRESENTATION THAT ARE NOT HISTORICAL OR CURRENT FACTS INCLUDING, BUT NOT LIMITED TO, THOSE RELATED TO OUR FINANCIAL AND BUSINESS EXPECTATIONS AND OUTLOOK, THE IMPACT OF THE EVOLVING AND UNCERTAIN HEALTHCARE ENVIRONMENT, STRATEGY AND GROWTHDRIVERS, UTILIZATION AND PATIENT VOLUME TRENDS, REVENUE VISIBILITY, ANTICIPATEDMEMBERRENEWALS OF GPO PARTICIPATION AGREEMENTS, CROSS AND UPSELL OPPORTUNITIES, ACQUISITIONACTIVITIES AND PIPELINE, REVENUE AVAILABLE UNDER CONTRACT, PURCHASESUNDEROUR SHARE REPURCHASE PROGRAM AND THE FINANCIAL IMPACT OF SHARE REPURCHASES, TAX REFORM AND COST SAVINGS EFFORTS, POTENTIAL DIVIDEND PAYMENTS, AND2020 FINANCIALGUIDANCE AND RELATED ASSUMPTIONS ARE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE FEDERALSECURITIES LAWS. FORWARD-LOOKING STATEMENTS MAY INVOLVE KNOWNAND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT MAY CAUSE THE ACTUAL RESULTS TO BE MATERIALLY DIFFERENT FROM HISTORICAL RESULTS OR FROM ANY FUTURE RESULTS OR PROJECTIONS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. ACCORDINGLY, READERSSHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD LOOKING STATEMENTS. READERS ARE URGED TO CONSIDER STATEMENTS IN THE CONDITIONAL OR FUTURE TENSES OR THAT INCLUDE TERMS SUCH AS “BELIEVES,” “BELIEF,” “EXPECTS,” “ESTIMATES,” “INTENDS,” “ANTICIPATES” OR “PLANS”TO BEUNCERTAINAND FORWARD-LOOKING.FORWARD-LOOKING STATEMENTS MAY INCLUDE COMMENTS REGARDING THE COMPANY ’S BELIEFS AND EXPECTATIONS AS TO FUTURE EVENTS AND TRENDS AFFECTING ITS BUSINESS AND ARE NECESSARILY SUBJECT TO UNCERTAINTIES, MANY OF WHICH ARE OUTSIDE COMPANY’S CONTROL. YOU SHOULD CAREFULLY READ COMPANY’S PERIODIC AND CURRENT FILINGS WITH THE OTC MARKETS FOR MORE INFORMATION ON POTENTIAL RISKS AND OTHER FACTORS THAT COULD AFFECT THE COMPANY AND ITS FINANCIAL CONDITION OR RESULTS OF OPERATIONS. FORWARD-LOOKING STATEMENTS SPEAKONLY AS OFTHE DATE THEY ARE MADE. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS. ‍NON-GAAP FINANCIALMEASURES–THIS PRESENTATIONINCLUDES CERTAIN “NON-GAAP FINANCIAL MEASURES” AS DEFINED IN REGULATION G UNDER THE SECURITIES EXCHANGE ACT OF 1934. SCHEDULES ARE ATTACHED THAT RECONCILE THE NON-GAAP FINANCIAL MEASURES INCLUDED IN THIS PRESENTATION TO THE MOST DIRECTLY COMPARABLE FINANCIAL MEASURES CALCULATEDAND PRESENTEDIN ACCORDANCEWITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN THE UNITED STATES. YOU SHOULD CAREFULLY READ PROGRESSIVE CARE’S PERIODIC AND CURRENTFILINGS ON THE OTCQB WEBSITE FOR DEFINITIONS AND FURTHER EXPLANATION AND DISCLOSURE REGARDING OUR USE OF NON-GAAP FINANCIAL MEASURES AND SUCH FILINGS SHOULD BE READ IN CONJUNCTION WITH THIS PRESENTATION.